Edition:
United Kingdom

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

4.21USD
12 Dec 2017
Change (% chg)

$-0.09 (-2.21%)
Prev Close
$4.30
Open
$4.27
Day's High
$4.33
Day's Low
$4.21
Volume
636
Avg. Vol
3,388
52-wk High
$15.12
52-wk Low
$3.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.428
Jun '17 0.00 -1.603
Mar '17 0.00 -0.428
FY 2016 Dec '16 0.00 -1.485
Sep '16 0.00 -3.686
Jun '16 0.00 -5.378
Mar '16 0.00 -4.545
FY 2015 Dec '15 0.00 -4.390
Sep '15 0.00 -4.733
Jun '15 0.00 -3.595
Mar '15 0.00 -5.331
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta -- 0.90 0.88
Price to Sales (TTM) -- 3.93 5.40
Price to Book (MRQ) 1.43 4.81 5.38
Price to Tangible Book (MRQ) 1.55 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 52.52 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 4.66 5.38
Sales - 5 Yr. Growth Rate -- 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 70.19 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 62.18 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 7.86 2.88 2.98
LT Debt to Equity (MRQ) 1.05 9.47 11.56
Total Debt to Equity (MRQ) 1.05 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.46 15.24
Operating Margin (TTM) -- 14.50 7.76
Operating Margin - 5 Yr. Avg. -- 14.42 10.75
Pre-Tax Margin (TTM) -- 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.74 11.17
Net Profit Margin (TTM) -- 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -- 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 953,213,833 864,673,366
Net Income/Employee (TTM) -2,630,375 112,151,384 101,717,513
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 0.00 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -57.10 11.42 11.00
Return on Assets - 5 Yr. Avg. -- 13.00 12.43
Return on Investment (TTM) -67.10 14.86 14.46
Return on Investment - 5 Yr. Avg. -- 17.00 16.28
Return on Equity (TTM) -67.53 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 16.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novus Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.25%
# of Holders: 30
Total Shares Held: 3,773,314
3 Mo. Net Change: 127,759
# New Positions: 3
# Closed Positions: 8
# Increased Positions: 8
# Reduced Positions: 12
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.